Maryland Daily Record Maryland's trusted source for business and legal news
U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Gaithersburg-based Novavax.
Tagged with: COVID-19 Montgomery County novavax vaccines
Read More »COVID booster dose from Gaithersburg-based Novavax approved
COVID-19 vaccine from Maryland-based Novavax approved by regulators
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults.
Tagged with: COVID-19 novavax vaccines
Read More »FDA advisers back Novavax COVID-19 shots as new US option
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the FDA backed a more traditional type of shot.
Read More »Md. biotech sees good results from respiratory virus vaccine trial
Novavax Inc., a Gaithersburg-based biotechnology company, on Tuesday announced that it had seen positive data from its phase 2 trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate. There is no approved vaccine for the virus, which is the most common ...
Tagged with: biotech gaithersburg Montgomery County novavax
Read More »Novavax adding up to 850 jobs in Montgomery County
A Gaithersburg-based vaccine company is planning to expand its local operations and create as many as 850 new jobs, state officials announced Wednesday. Novavax, which already has 400 full-time employees, signed a lease last month for 150,000 additional square feet ...
Tagged with: Larry Hogan Mike Gill novavax vaccine
Read More »Novavax net loss up, revenue down
Novavax Inc., of Gaithersburg, a clinical-stage vaccine company, reported its net loss more than doubled and revenue dropped $2 million for the quarter ended Dec. 31. Novavax posted a net loss of $31.5 million, or 13 cents per share, compared ...
Tagged with: novavax
Read More »Novavax loss increases
Novavax Inc., of Gaithersburg, a biopharmaceutical company focused on creating vaccines, reported higher revenues but an increased loss for the third quarter. Novavax’s net loss was $19.7 million, or 8 cents per share, for the quarter, compared with a net ...
Read More »Novavax loss, revenue increase
Novavax Inc., of Gaithersburg, a biopharmaceutical company creating vaccines for infectious diseases worldwide, reported an increase in both revenue and net loss for the second quarter. Novavax had a net loss of $17.9 million, or 8 cents per share, for ...
Read More »Novavax rises on respiratory virus vaccine study
NEW YORK — Novavax Inc. on Tuesday reported positive results from an early clinical trial of a respiratory virus vaccine, sending its shares higher. The company is studying a vaccine intended to prevent respiratory syncytial virus. Novavax said the vaccine ...
Tagged with: biotechnology Business medicine novavax Stocks Stocks vaccine
Read More »Rockville-based Novavax reports larger quarterly loss
Novavax Inc., of Rockville, a drug delivery company developing vaccines aimed at a broad range of infectious diseases worldwide, reported a net loss of $10 million, or 7 cents per diluted share, for the first quarter of 2013, compared to a net loss of $7.3 million, or 6 cents per share, for the year-ago period.
Tagged with: Business earnings maryland novavax rockville Stocks
Read More »
